Show items per page
Elements: 4
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
Factors influencing the retention rates of Tumour Necrosis Factor inhibitors in patients with axial spondyloarthritis Nissen, Michaël 2020
add to browser selection
Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase ii study Mease, Philip J; Gladman, Dafna D; Deodhar, Atul; McGonagle, Dennis G; ... Helliwell, Philip S 2020
add to browser selection
Treatment response and drug retention rates in 24 195 biologic-naïve patients with axial spondyloarthritis initiating TNFi treatment: routine care data from 12 registries in the EuroSpA collaboration Ørnbjerg, Lykke Midtbøll; Brahe, Cecilie Heegaard; Askling, Johan; Ciurea, Adrian; ... Østergaard, Mikkel 2019
add to browser selection
Long term amelioration of established collagen-induced arthritis achieved with short term therapy combining anti-CD3 and anti-TNF treatments Depis, Fabien 2012